Press Release: Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion

Optimi Health Corp. has established a discretionary equity line of credit of up to US$100 million with Seven Knots, LLC, allowing the company to sell common shares at its own discretion, subject to pricing formulas, per-draw limits, ownership caps, and Canadian Securities Exchange policies. As part of the arrangement, Optimi issued Seven Knots a US$1.5 […]